Cardioprotective Action of Perindopril versus Candesartan in Renovascular Hypertensive Rats
- 1 September 2004
- journal article
- basic pharmacology
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 18 (5) , 353-362
- https://doi.org/10.1007/s10557-005-5059-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- ACE-Inhibition and Angiotensin II Receptor Blockers in Chronic Heart Failure: Pathophysiological Consideration of the Unresolved BattleCardiovascular Drugs and Therapy, 2003
- Local Cardiac Renin–Angiotensin System: Hypertension and Cardiac FailureJournal of Molecular and Cellular Cardiology, 2002
- Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trialsJournal of the American College of Cardiology, 2002
- Clinical trials of angiotensin receptor blockers in heart failure: what do we know and what will we learn?American Journal of Hypertension, 2002
- Role of Angiotensin and Its Inhibition in Hypertension, Ischemic Heart Disease, and Heart FailureHypertension, 2001
- Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: Observations from Val-HeFT and CALMJournal of Human Hypertension, 2001
- Angiotensin II and the HeartHypertension, 2000
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 2000
- Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout MiceCirculation, 1998
- Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 1997